Analyst Ratings for Cyteir Therapeutics (CYT)

CYT Rating Summary

  |   Expand Research on CYT
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/5/2024 BofA Securities Tazeen Ahmad Downgrade Underperform
(Neutral)		 3.00
(2.00)		 3.06
(3.02)		 -1.31% Details
2/3/2023 Morgan Stanley Jeffrey Hung Downgrade Underweight
(Equalweight)		 2.00
(4.00)		 1.57
(3.02)		 92.36% Details